The 20 Best Squamous Cell Skin Carcinoma Doctors Near Me in Baltimore, MD

Dr. Lipson is an internationally-recognized skin cancer and immunotherapy specialist at Johns Hopkins. He received his medical degree in 2005 from the Mount Sinai School of Medicine in New York City, where he graduated with distinction in research. He completed his internship and residency in Internal Medicine at The Johns Hopkins Hospital, and completed a Medical Oncology fellowship at the Johns Hopkins Kimmel Cancer Center. Dr. Lipson leads cutting edge clinical trials for patients with melanoma and other skin cancers. As a member of the Johns Hopkins Melanoma and Cancer Immunology Programs, he focuses on evaluating novel therapies for patients with high-risk or advanced disease. Dr. Lipson’s publications include the first reports of organ transplant recipients treated with immune checkpoint inhibitors for advanced cancer, and the first description of kidney retransplantation performed after immunotherapy–related organ rejection. Based on his published work, Dr. Lipson initiated a clinical trial testing a novel combination of immune-based therapies for kidney transplant recipients with advanced selected cancers. Results from this trial - the first of its kind - were reported in 2022 at an international oncology meeting. Dr. Lipson is a leader in the clinical development of relatlimab, an antibody blocking the LAG-3 immune checkpoint. He leads a phase 2 trial testing combination immune checkpoint inhibitor therapy—including anti-LAG-3—for patients with advanced basal cell carcinoma. In June 2021, Dr. Lipson presented findings from the first phase 3 study establishing the LAG-3 pathway as the third immune checkpoint pathway in history, after CTLA-4 and PD-1, for which blockade has clinical benefit. This trial supported the FDA's approval of a new therapy for patients with advanced melanoma. In addition to his research activities, Dr. Lipson is an educator in the field of cancer immunotherapy. Many of his lectures focus on the management of immune-mediated drug toxicities associated with novel cancer drugs. Dr. Lipson conducts regular clinical practices in Baltimore, Maryland and at Sibley Memorial Hospital in Washington, D.C. as part of the multidisciplinary Melanoma Program at Johns Hopkins. Dr. Lipson is rated as a Distinguished provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Pancreaticoduodenectomy. Dr. Lipson is board certified in American Board Of Internal Medicine.

Jennifer Powers is a Plastic Surgeon and a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Powers is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Actinic Keratosis, Pityriasis Rubra Pilaris, and Squamous Cell Skin Carcinoma. Dr. Powers is board certified in American Board Of Dermatology.

Dr. Harry Quon is an associate professor of radiation oncology and molecular radiation sciences at the Johns Hopkins University School of Medicine. He also holds appointments in oncology and in otolaryngology - head and neck surgery. His area of clinical expertise is radiation treatment for head and neck cancers. He serves as the co-director of the Johns Hopkins Head and Neck Cancer Multidisciplinary Clinic. Dr. Quon received his M.D. from the University of Toronto Institute of Medical Science. He completed his residency at the Princess Margaret Hospital in Ontario and performed a fellowship in radiation oncology at the Princess Margaret Hospital and the Beth Israel Medical Center. Make A Gift. Dr. Quon is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 21 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Dry Mouth, Gastrostomy, and Prostatectomy. Dr. Quon is board certified in American Board Of Radiology.

Dr. Ana Kiess's clinical focus is on the treatment of prostate cancer and head and neck cancers with external beam radiotherapy and radiopharmaceutical therapies. Her research concentrates on the integration of new radiopharmaceutical therapies and dosimetry techniques into the clinic. Dr. Kiess received her bachelors of science degree in chemical engineering from the University of Virginia, after which she obtained a doctorate of medicine and a doctorate of philosophy degree in biomedical engineering from Duke University. Following medical school, she matriculated to the resident staff at Memorial Sloan Kettering Cancer Center, receiving extensive oncologic training and research experience. She also completed a postdoctoral research fellowship at Johns Hopkins University in the Department of Radiology. Make A Gift. Dr. Kiess is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Prostate Cancer, Laryngeal Cancer, Acinic Cell Carcinoma of Salivary Glands, Gastrostomy, and Adenoidectomy. Dr. Kiess is board certified in American Board Of Radiology.

Christine Gourin, M.D. M.P.H., is a head and neck surgical oncologist and palliative medicine specialist who treats patients with head and neck tumors, including tumors of the skin, melanoma, oral cavity, larynx, oropharynx, neck, salivary glands, sinuses, and skull base. Dr. Gourin received her medical degree from the State University of New York-Health Science Center at Brooklyn/Downstate Medical Center. Dr. Gourin trained in General Surgery and Otolaryngology-Head and Neck Surgery at the University of Vermont, followed by a fellowship in Advanced Head and Neck Oncologic Surgery at the University of Pittsburgh and a fellowship in Hospice and Palliative Medicine at Johns Hopkins University. She has authored over 200 peer-reviewed journal articles, 24 book chapters and two books: Medical and Surgical Management of Thyroid and Parathyroid Diseases and The Johns Hopkins Patient Guide to Head and Neck Cancer. She is on the Editorial Board of The Laryngoscope and is a reviewer for numerous other head and neck surgery journals. Dr. Gourin is a nationally and internationally recognized expert in quality of care and outcomes with a lifelong interest in improved symptom management, communication, access to high-quality affordable care, and palliative medicine in head and neck cancer. She has an active head and neck surgical oncology practice and has been named to America’s Top Physicians and Best Doctors in America annually since 2005. She is the Director of the Johns Hopkins Head and Neck Cancer Supportive Care Clinic. Dr. Gourin is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 19 other conditions, according to our data. Her clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Tongue Cancer, Laryngectomy, and Gastrostomy. Dr. Gourin is board certified in American Board Of Internal Medicine and Head And Neck Surgery.

Wayne Koch is a national and international leader in head and neck oncologic surgery, caring for patients with cancers of the oral cavity, salivary gland, larynx, hypopharynx, oropharynx and thyroid. Among Dr. Koch's landmark publications are studies demonstrating how key molecular events such as p53 mutation and human papillomavirus (HPV) contribute to the development of head and neck cancer. His peer-reviewed publications include six articles in the New England Journal of Medicine. Dr. Koch is also involved in humanitarian outreach focused on training surgeons in several African nations. He has served as president of the American Head and Neck Society, the national organization of head and neck cancer surgeons in the USA. Dr. Koch is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 19 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Human Papillomavirus Infection, Laryngectomy, and Gastrostomy. Dr. Koch is board certified in Head And Neck Surgery.

Dr. Kofi Derek Owusu Boahene is a professor of otolaryngology-head and neck surgery and dermatology at the Johns Hopkins University School of Medicine. He is the Director of the Division of Facial Plastics and Reconstructive Surgery and the director for the facial plastics fellowship training program. His practice encompasses the entire spectrum of facial plastic and reconstructive surgery including cosmetic and reconstructive aspects. Dr. Boahene is a leading expert in facial paralysis surgery and facial nerve injuries and has pioneered innovative treatment protocols and surgical techniques in facial reanimation. He is the director of the Johns Hopkins Facial Nerve center dedicated to restoring facial balance, symmetry and animation to those who have suffered from facial paralysis and facial nerve disorders. As an expert microsurgeon, Dr. Boahene routinely performs some of the most complex facial reconstruction procedures on the face including rebuilding of an entire nose, lip, jaw and facial defects resulting from cancer treatment, traumatic injuries or as a result of birth defects. He uses cutting edge 3-D technology, image-guided technology and tissue transplanted from other parts of the body to restore or replace missing tissues. He is a key member of the Johns Hopkins facial transplant program. His cosmetic experience is broad and draws from patients across the globe. He routinely performs rhinoplasties, eyelid surgery, face lifts and other facial enhancing procedures. As a skull base surgeon, Dr. Boahene has pioneered minimally invasive techniques for removal of skull base and brain tumors, repairing CSF leaks and has authored a major textbook on this subject. Dr. Boahene received his undergraduate degree from the University of Central Arkansas. He graduated summa cum laude from Meharry Medical College in Nashville, Tennessee, completed a five-year surgical residency training program in otolaryngology-head and neck surgery at the Mayo Clinic in Rochester, Minnesota, and received fellowship training in facial plastic and reconstructive surgery at the University of Minnesota. As the recipient of the prestigious Mayo Brothers Distinguished Fellowship Award, Dr. Boahene was awarded additional craniofacial surgery training in Adelaide, Australia. He also received the Jack R. Anderson Prize for Scholastic Excellence for attaining the highest score nationally on the American Academy of Facial Plastic and Reconstructive Surgery certification exam. Dr. Boahene serves as on the Board of Governors or the American Academy Facial Plastic and Reconstructive Surgery. He is a member of several professional organizations, including the American Academy of Facial Plastic and Reconstructive Surgery and the American Academy of Otolaryngology-Head and Neck Surgery. In 1993, Dr. Kofi Boahene received the Alpha Omega Alpha Medical. Dr. Boahene is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Facial Paralysis, Bell's Palsy, Recurrent Peripheral Facial Palsy, Septoplasty, and Gastrostomy. Dr. Boahene is board certified in American Board Of Facial Plastic And Reconstructive Surgery and Head And Neck Surgery.

Dr. Grant Anhalt is a professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include autoimmune skin diseases and dermatoimmunology. Dr. Anhalt serves as the director of the Dermatoimmunology Laboratory at the Johns Hopkins School of Medicine. He received his undergraduate degree and his M.D. from the University of Manitoba. He completed a residency in internal medicine at the Health Sciences Center in Winnipeg, Canada and a residency in dermatology at the University of Michigan. He performed a fellowship in immunodermatology at the University of Michigan Medical Center. Dr. Anhalt joined the Johns Hopkins faculty in 1982. He was interim chair of the Department of Dermatology from 1996 to 2001. His research interests include autoimmunity, bullous skin diseases and pemphigus and pemphigoid. Dr. Anhalt serves on the medical advisory board for the International Pemphigus & Pemphigoid Foundation. He has been recognized as a top doctor in the Washington Post Magazine, Baltimore Magazine and Castle Connolly Guide. He is a member of several professional organizations, including the American Academy of Dermatology, American Dermatologic Association and American Society for Clinical Investigation. CV http://www.hopkinsmedicine.org/dermatology/our_experts/CV/Anhalt_CV_2014.docx. Dr. Anhalt is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Pemphigus Vulgaris, Pemphigus, Bullous Pemphigoid, and Pemphigus Foliaceus. Dr. Anhalt is board certified in American Board Of Dermatology.

Dr. Damon S. Cooney is an associate professor of plastic and reconstructive surgery at the Johns Hopkins University School of Medicine. Dr. Cooney performs all types of general plastic surgery but specializes in microvascular reconstruction (free flaps). A particular focus of his clinical practice is improving the functional and aesthetic results of head and neck reconstruction. He completed additional fellowship training at the University of Pittsburgh to become an expert in microsurgical techniques for reconstructing the extremities, trunk, breast, and head and neck following traumatic and/or oncological defects. Dr. Cooney earned a Ph.D. from Ohio State University Department of Molecular, Cellular and Development Biology. Dr. Cooney’s clinical and basic research focus is composite tissue allotransplantation (CTA). He is a member of the Composite Tissue Allotransplantation team at Johns Hopkins and helps conduct human hand and face transplantation trials. His laboratory work includes engineering human tissues for reconstructive purposes, nerve regeneration, microsurgical education and inducing tolerance in order to reduce or eliminate the need for systemic immunosuppression in transplantation patients. Dr. Cooney has published numerous peer-reviewed articles and book chapters in addition to being a reviewer for plastic surgery journals. He is a founding member of the American Society for Reconstructive Transplantation. Dr. Cooney is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Keloids, Hidradenitis Suppurativa, Squamous Cell Skin Carcinoma, Osteotomy, and Abdominal Wall Surgery. Dr. Cooney is board certified in American Board Of Plastic Surgery.

"Daniel J. Lewis, M.D. is a dual fellowship-trained Mohs and reconstructive surgeon and Assistant Professor of Dermatology at Johns Hopkins University School of Medicine. He leads the Mohs surgery unit at the Johns Hopkins Outpatient Center (JHOC), the hospital's flagship facility in downtown Baltimore. He is also heavily involved in education as the director of the JHOC resident surgery clinic and as core faculty for the Micrographic Surgery and Dermatologic Oncology fellowship. Dr. Lewis earned a B.A. in Biology from the University of Pennsylvania, earned his M.D. at Baylor College of Medicine while completing a research fellowship at The University of Texas MD Anderson Cancer Center, and completed his internship at Memorial Sloan Kettering Cancer Center. He then returned to Penn for dermatology residency, serving as chief resident at the country's No. 1-ranked dermatology program by Doximity. At Penn, he pursued further specialization with two year-long post-doctoral fellowships in cutaneous oncology and Mohs micrographic surgery. During his Mohs fellowship at Penn, Dr. Lewis worked at the largest academic Mohs surgery center in the country alongside leaders in the field and pioneers in the use of Mohs surgery with immunohistochemistry, complex reconstruction, high-risk tumors, and tumors on specialty sites. Dr. Lewis has authored over 90 peer-reviewed manuscripts in high-impact journals such as Journal of the American Academy of Dermatology, JAMA Dermatology, and Journal of Investigative Dermatology. He has also served on the Editorial Board of the International Journal of Dermatology and has authored multiple textbook chapters as well as two editions of the book Practical Ways to Improve Patient Adherence, named the winner of the 2022 ""Best Overall"" Dermie Award by Dermasphere. Dr. Lewis is an aspiring leader in cutaneous oncology and was named Post-Doctoral Trainee of the Year in 2022 by ADEN, winner of the 2022 ASDS Young Investigators Writing Competition, and a Rising Scholar by the Dermatology Foundation in 2023. He is a member of the Alpha Omega Alpha Honor Medical Society. He is passionate about Mohs micrographic surgery and has clinical interests in advanced facial reconstruction, Mohs surgery with immunohistochemistry, facial anatomy, Merkel cell carcinoma, melanoma, and patient adherence.". Dr. Lewis is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 10 other conditions, according to our data. His clinical expertise encompasses Cutaneous T-Cell Lymphoma (CTCL), T-Cell Lymphoma, Mycosis Fungoides, and Sezary Syndrome. Dr. Lewis is board certified in American Board Of Dermatology.

Dr. Visvanathan is a Professor on faculty at Johns Hopkins. She is a practicing medical oncologist and cancer epidemiologist focused on translating discoveries to the clinic and population as a whole. She directs the Clinical Cancer Genetics and Prevention service at Johns Hopkins Sidney Kimmel Comprehensive Cancer Center (SKCCC) and is an active member of the Breast and Ovarian Program and Cancer Prevention and Control Program. Dr. Visvanathan is also Director of the Cancer Epidemiology Track in the Department of Epidemiology at Johns Hopkins Bloomberg School of Public Health. With her research centered on primary and secondary prevention of breast and ovarian cancer, her goal is to reduce the incidence of and mortality from breast cancer globally by conducting impactful studies at the local, national, and international levels. Specifically, she focuses on the identification of atrisk groups, potential biomarkers of risk and prognosis and evaluation of preventive agents across the continuum. She conducts both observational studies and early phase clinical trials. She also teaches and mentors the next generation of clinicians and cancer researchers. Dr. Visvanathan has also served on national committees focused on Breast Cancer Risk Reduction, Breast Cancer Genetics and Cancer Disparities. She has also co-chaired National Guidelines on Breast Cancer Endocrine Prevention. Locally, serving on the Maryland State Cancer Council. Dr. Visvanathan received her medical degree from the University of Sydney in Australia. She subsequently went on to complete training in internal medicine and medical oncology, including a period as chief resident at Royal Prince Alfred Hospital. She then did further training in Medical Oncology at Johns Hopkins and also obtained a master’s degree in clinical/cancer epidemiology at Johns Hopkins Bloomberg School of Public Health. This was followed by a postdoctoral fellow before coming on to faculty in both the Johns Hopkins School of Medicine and Bloomberg School of Public Health. Dr. Visvanathan is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 6 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Ovarian Cancer, Menopause, Hormone Replacement Therapy (HRT), and Salpingo-Oophorectomy.

William Houck is an Oncologist practicing medicine in Baltimore, Maryland. Dr. Houck is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 73 other conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Lung Cancer, Chronic B-Cell Leukemia (CBCL), and Richter Syndrome. Dr. Houck is board certified in American Board Of Internal Medicine.

Zaineb Makhzoumi is a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Makhzoumi is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 7 other conditions, according to our data. Her clinical expertise encompasses Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, Melanoma, and Actinic Keratosis.

Manisha Loss is a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Loss is rated as an Advanced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Multiple Familial Trichoepithelioma, Trichoepithelioma, and Actinic Keratosis.

Fyza Shaikh is an Assistant Professor in Cancer Immunology in the Department of Oncology in the Sidney Kimmel Comprehensive Cancer Center. She joined the faculty after completing her fellowship in medical oncology at Johns Hopkins School of Medicine (JHSOM) and residency in internal medicine at the University of Pittsburgh Medical Center as part of the ABIM research pathway. She received her MD and PhD in Microbiology and Immunology at Vanderbilt University School of Medicine. The Shaikh lab at JHSOM is focused on how the microbiome impacts host immunological responses to tumorigenesis and anti-tumor responses to immunomodulatory agents. The lab uses a combination of translational approaches using samples collected from human cohort studies and clinical trials as well as murine models to ask more detailed mechanistic questions and works across multiple tumor types (melanoma, lung, esophageal, head and neck, etc). The overall approach uses combination of clinical, computational, and lab-based techniques using a rich biorepository containing clinically annotated metadata with known and putative biomarkers of ICI response, such as PD-L1 and tumor mutational burden, paired with longitudinal fecal and plasma samples that correlate with clinical milestones (i.e. response/nonresponse by imaging and treatment-related toxicity). The goal is to focus on microbial functionality and build defined bacterial consortia that can then be tested in murine models to define colonization, metabolomics, and intra-tumoral immune response. This translational approach, with cross-sectional and longitudinal analysis of human samples, paired with mechanistic studies in murine models, has the potential to address both limitations in previously published studies and generate new hypotheses to make advances in this field and improve ICI responses for patients with advanced malignancies. Dr. Shaikh is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Melanoma, and Esophageal Cancer. Dr. Shaikh is board certified in American Board Of Internal Medicine.

Dr. Jaroslaw Jedrych is an assistant professor of dermatology at the Johns Hopkins University School of Medicine. His areas of clinical expertise include dermatopathology and anatomic pathology. Dr. Jedrych received his M.D. from the Warsaw Medical University. He completed his residency in anatomic pathology at Yale School of Medicine, where he served as chief resident. He then completed his fellowship in oncologic pathology at Memorial Sloan Kettering Cancer Center, where he served as chief fellow, and a dermatopathology fellowship at University of Pittsburgh Medical Center. Dr. Jedrych is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 3 other conditions, according to our data. His clinical expertise encompasses Trichoepithelioma, Epidermodysplasia Verruciformis, Warts, and Grover's Disease. Dr. Jedrych is board certified in American Board Of Pathology.

Maie John is an Otolaryngologist practicing medicine in Baltimore, Maryland. Dr. John is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Melanoma, Glossectomy, and Gastrostomy. Dr. John is board certified in Head And Neck Surgery.

Jason Molitoris is a Radiologist and a Radiation Oncologist practicing medicine in Baltimore, Maryland. Dr. Molitoris is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Adult Soft Tissue Sarcoma, Familial Prostate Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Molitoris is board certified in American Board Of Radiology.

Risa Jampel is a Dermatologist practicing medicine in Baltimore, Maryland. Dr. Jampel is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Melanoma, Familial Atypical Multiple Mole Melanoma Syndrome, Giant Congenital Nevus, and Giant Congenital Melanocytic Nevus.

Regina Anderson is an Internal Medicine provider practicing medicine in Baltimore, Maryland. Dr. Anderson is rated as an Experienced provider by MediFind in the treatment of Squamous Cell Skin Carcinoma. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Actinic Keratosis, Warts, Basal Cell Skin Cancer, and Squamous Cell Skin Carcinoma.